Metraipolis › archive › dc_9293b0ca5732
Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and… — Europe PMC PMID:41041636
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41041636
- DOI
- 10.3389/fphar.2025.1668511
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:13:47.553Z
- SHA-256 of the archived text
826b053427b6df574db73ad5c1da12e4e0f479a6c1bdc4e8b9f267fac906113c- Stable URL of this page
https://metraipolis.com/documento/dc_9293b0ca5732
How to cite
Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and… — Europe PMC PMID:41041636 — Europe PMC (en), https://europepmc.org/article/MED/41041636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9293b0ca5732 (Metraipolis archive dc_9293b0ca5732, sha256 826b053427b6df574db73ad5c1da12e4e0f479a6c1bdc4e8b9f267fac906113c)
BibTeX
@misc{dc9293b0ca5732,
title = {Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and… — Europe PMC PMID:41041636},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41041636},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9293b0ca5732; sha256 826b053427b6df574db73ad5c1da12e4e0f479a6c1bdc4e8b9f267fac906113c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041636. Agents can read the archived copy with the MCP tool read_document.